Birdwatch Note
2024-02-06 10:46:42 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
While corn silk (specifically maysin) inhibits the PC-3 cancer cell growth and may have a strong therapeutic potential for the treatment of either chemo-resistant or androgen-independent human prostate cancer, no verified claims of cures have been made, let alone in 3 months https://europepmc.org/article/med/25445226
Written by 6C8DEEE815042E6B705E351A9CC83AA7EEAD578F7AFE443B897B55CEA7A8EF3C
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1754764893742395439
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1754818896819786021
- noteId - 1754818896819786021
- participantId -
- noteAuthorParticipantId - 6C8DEEE815042E6B705E351A9CC83AA7EEAD578F7AFE443B897B55CEA7A8EF3C
- createdAtMillis - 1707216402614
- tweetId - 1754764893742395439
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 1
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- While corn silk (specifically maysin) inhibits the PC-3 cancer cell growth and may have a strong therapeutic potential for the treatment of either chemo-resistant or androgen-independent human prostate cancer, no verified claims of cures have been made, let alone in 3 months https://europepmc.org/article/med/25445226
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-02-06 10:46:42 UTC (1707216402614) |
2024-02-06 13:15:46 UTC (1707225346811) |
CURRENTLY_RATED_HELPFUL | 2024-02-07 00:47:28 UTC (1707266848650) |
CURRENTLY_RATED_HELPFUL | 2024-02-06 13:15:46 UTC (1707225346811) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-02-06 15:33:21 -0600 | Rating Details | |
| 2024-02-06 07:22:52 -0600 | Rating Details | |
| 2024-02-06 07:16:06 -0600 | Rating Details | |
| 2024-02-06 07:15:15 -0600 | Rating Details | |
| 2024-02-06 07:07:23 -0600 | Rating Details | |
| 2024-02-06 07:05:39 -0600 | Rating Details | |
| 2024-02-06 06:58:25 -0600 | Rating Details | |
| 2024-02-06 06:54:09 -0600 | Rating Details | |
| 2024-02-06 06:50:08 -0600 | Rating Details | |
| 2024-02-06 06:48:41 -0600 | Rating Details | |
| 2024-02-06 06:46:49 -0600 | Rating Details | |
| 2024-02-06 06:22:14 -0600 | Rating Details | |
| 2024-02-06 06:16:31 -0600 | Rating Details | |
| 2024-02-06 06:08:45 -0600 | Rating Details | |
| 2024-02-06 05:56:33 -0600 | Rating Details | |
| 2024-02-06 05:56:32 -0600 | Rating Details | |
| 2024-02-06 05:55:47 -0600 | Rating Details | |
| 2024-02-06 05:53:50 -0600 | Rating Details | |
| 2024-02-06 05:49:21 -0600 | Rating Details | |
| 2024-02-06 05:47:22 -0600 | Rating Details | |
| 2024-02-06 05:44:28 -0600 | Rating Details | |
| 2024-02-06 05:38:27 -0600 | Rating Details | |
| 2024-02-06 05:37:22 -0600 | Rating Details | |
| 2024-02-06 05:35:58 -0600 | Rating Details | |
| 2024-02-06 05:32:58 -0600 | Rating Details | |
| 2024-02-06 05:30:07 -0600 | Rating Details | |
| 2024-02-06 05:19:59 -0600 | Rating Details | |
| 2024-02-06 05:12:16 -0600 | Rating Details | |
| 2024-02-06 05:11:04 -0600 | Rating Details | |
| 2024-02-06 20:59:12 -0600 | Rating Details | |
| 2024-02-06 18:14:58 -0600 | Rating Details | |
| 2024-02-06 13:24:09 -0600 | Rating Details | |
| 2024-02-06 06:46:28 -0600 | Rating Details | |
| 2024-02-06 06:26:41 -0600 | Rating Details | |
| 2024-02-06 06:11:58 -0600 | Rating Details | |
| 2024-02-06 06:11:16 -0600 | Rating Details | |
| 2024-02-06 05:59:20 -0600 | Rating Details | |
| 2024-02-06 05:59:16 -0600 | Rating Details | |
| 2024-02-06 05:57:35 -0600 | Rating Details | |
| 2024-02-06 05:55:40 -0600 | Rating Details | |
| 2024-02-06 05:49:41 -0600 | Rating Details | |
| 2024-02-06 05:46:28 -0600 | Rating Details | |
| 2024-02-06 05:43:38 -0600 | Rating Details | |
| 2024-02-06 05:41:30 -0600 | Rating Details | |
| 2024-02-06 05:39:50 -0600 | Rating Details | |
| 2024-02-06 05:39:43 -0600 | Rating Details | |
| 2024-02-06 05:36:56 -0600 | Rating Details | |
| 2024-02-06 05:18:39 -0600 | Rating Details | |
| 2024-02-06 04:53:34 -0600 | Rating Details |